Research is being conducted on dual-targeting CDKs regulators as a potential cancer therapy. The approach is being explored for various types of cancer, including breast, pancreatic, and head and neck cancer. The therapy's effectiveness and potential applications are being investigated, with some studies focusing on specific molecular targets and others examining its impact on the tumor microenvironment.